Wermke, Martin
University Hospital Carl Gustav Carus · Nationales Centrum für Tumorerkrankungen Dresden · Technische Universität Dresden
3 papers on CoChatORCID 0000-0002-4844-4087
Most cited papers
- Verified
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
Wermke, M., Araujo, D. M., Chatterjee, M., Tsimberidou, A. M., Holderried, T. A. W., Jazaeri, A. A., Reshef, R., Bokemeyer, C., Alsdorf, W., Wetzko, K., et al. (2025) · Nature Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 73
- Verified
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial
Wermke, M., Eckoldt, J., Götze, K. S., Klein, S. A., Bug, G., de Wreede, L. C., Kramer, M., Stölzel, F., von Bonin, M., Schetelig, J., et al. (2018) · The Lancet Haematology
Iron Metabolism and DisordersHematopoietic Stem Cell Transplantation
Cited by 59
- Verified
Enhanced labile plasma iron in hematopoietic stem cell transplanted patients promotes Aspergillus outgrowth
Petzer, V., Wermke, M., Tymoszuk, P., Wolf, D., Seifert, M., Ovaçin, R., Berger, S., Orth-Höller, D., Loacker, L., Weiss, G., et al. (2019) · Blood Advances
Antifungal resistance and susceptibilityIron Metabolism and Disorders
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free